5I94

Crystal structure of human glutaminase C in complex with the inhibitor UPGL-00019


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.98 Å
  • R-Value Free: 0.231 
  • R-Value Work: 0.173 
  • R-Value Observed: 0.175 

wwPDB Validation 3D Report Full Report


This is version 1.2 of the entry. See complete history


Literature

Design and evaluation of novel glutaminase inhibitors.

McDermott, L.A.Iyer, P.Vernetti, L.Rimer, S.Sun, J.Boby, M.Yang, T.Fioravanti, M.O'Neill, J.Wang, L.Drakes, D.Katt, W.Huang, Q.Cerione, R.

(2016) Bioorg Med Chem 24: 1819-1839

  • DOI: 10.1016/j.bmc.2016.03.009
  • Primary Citation of Related Structures:  
    5FI2, 5FI7, 5FI6, 5I94

  • PubMed Abstract: 
  • A novel set of GAC (kidney glutaminase isoform C) inhibitors able to inhibit the enzymatic activity of GAC and the growth of the triple negative MDA-MB-231 breast cancer cells with low nanomolar potency is described. Compounds in this series have a r ...

    A novel set of GAC (kidney glutaminase isoform C) inhibitors able to inhibit the enzymatic activity of GAC and the growth of the triple negative MDA-MB-231 breast cancer cells with low nanomolar potency is described. Compounds in this series have a reduced number of rotatable bonds, improved ClogPs, microsomal stability and ligand efficiency when compared to the leading GAC inhibitors BPTES and CB-839. Property improvements were achieved by the replacement of the flexible n-diethylthio or the n-butyl moiety present in the leading inhibitors by heteroatom substituted heterocycloalkanes.


    Organizational Affiliation

    Cornell University, Department of Molecular Medicine, Ithaca, NY 14853, USA; Cornell University, Department of Chemistry and Chemical Biology, Ithaca, NY 14853, USA.



Macromolecules
Find similar proteins by:  (by identity cutoff)  |  Structure
Entity ID: 1
MoleculeChainsSequence LengthOrganismDetailsImage
Glutaminase kidney isoform, mitochondrialABCD539Homo sapiensMutation(s): 0 
Gene Names: GLSGLS1KIAA0838
EC: 3.5.1.2
Find proteins for O94925 (Homo sapiens)
Explore O94925 
Go to UniProtKB:  O94925
NIH Common Fund Data Resources
PHAROS  O94925
Protein Feature View
Expand
 ( Mouse scroll to zoom / Hold left click to move )
  • Reference Sequence
Small Molecules
Ligands 1 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
69V
Query on 69V

Download CCD File 
A, B
2-phenyl-N-{5-[4-({5-[(phenylacetyl)amino]-1,3,4-thiadiazol-2-yl}oxy)piperidin-1-yl]-1,3,4-thiadiazol-2-yl}acetamide
C25 H25 N7 O3 S2
BAGWZESOKRULGY-UHFFFAOYSA-N
 Ligand Interaction
External Ligand Annotations 
IDBinding Affinity (Sequence Identity %)
69VIC50:  30   nM  BindingDB
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.98 Å
  • R-Value Free: 0.231 
  • R-Value Work: 0.173 
  • R-Value Observed: 0.175 
  • Space Group: P 1 21 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 49.44α = 90
b = 137.79β = 94.68
c = 175.755γ = 90
Software Package:
Software NamePurpose
PHENIXrefinement
HKL-2000data reduction
HKL-2000data scaling
PHENIXphasing

Structure Validation

View Full Validation Report



Entry History & Funding Information

Deposition Data

  • Deposited Date: 2016-02-19 
  • Released Date: 2016-05-11 
  • Deposition Author(s): Huang, Q., Cerione, R.

Funding OrganizationLocationGrant Number
National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)United StatesGM040654
National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)United StatesGM047458

Revision History 

  • Version 1.0: 2016-05-11
    Type: Initial release
  • Version 1.1: 2017-09-20
    Changes: Advisory, Author supporting evidence, Database references, Derived calculations
  • Version 1.2: 2019-12-25
    Changes: Author supporting evidence